SCHEMBL30270968

SCHEMBL30270968

CC(C)(C)OC(=O)N1CCN(c2cc(=O)n3nc(Br)sc3n2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACKR3 P25106 2/20 0.49
▸ CKS1B P61024 2/20 0.44
▸ SKP1 P63208 2/20 0.44
▸ SKP2 Q13309 2/20 0.44
▸ ITGA2B P08514 3/20 0.44
▸ ITGB3 P05106 1/20 0.44
▸ MAP4K4 O95819 1/20 0.43
▸ GPR119 Q8TDV5 3/20 0.41
▸ KCNH2 Q12809 2/20 0.41
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ RET P07949 1/20 0.41
▸ ABCB1 P08183 1/20 0.40
▸ ABCG2 Q9UNQ0 1/20 0.40
▸ DDB1 Q16531 1/20 0.40
▸ CRBN Q96SW2 1/20 0.40
▸ P2RX3 P56373 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ SMPD3 Q9NY59 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL367933 0.86 ITGA2B (0.63) ACKR3CKS1BSKP1SKP2ITGA2B
SCHEMBL368501 0.84 ITGA2B (0.51) CKS1BSKP1SKP2ITGA2BITGB3
SCHEMBL30270990 0.83 RET (0.41) ACKR3ITGA2BITGB3SMN1; SMN2RET
SCHEMBL15130116 0.83 ITGA2B (0.45) ACKR3CKS1BSKP1SKP2ITGA2B
SCHEMBL15137974 0.81 SMARCA2 (0.44) ACKR3CKS1BSKP1SKP2ITGA2B
SCHEMBL15137944 0.80 ALDH1A1 (0.44) ACKR3CKS1BSKP1SKP2ITGA2B
SCHEMBL359637 0.80 ITGA2B (0.56) CKS1BSKP1SKP2ITGA2BITGB3
SCHEMBL15137937 0.80 ITGA2B (0.46) ACKR3CKS1BSKP1SKP2ITGA2B
SCHEMBL368819 0.80 ITGA2B (0.55) ACKR3ITGA2BLMNAMAPT
SCHEMBL15130157 0.79 ITGA2B (0.49) ACKR3CKS1BSKP1SKP2ITGA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4416156-A1 COMPOUNDS AND METHODS FOR MODULATING NUCLEIC ACID SPLICING Remix Therapeutics Inc. (US) 2024-08-21 — — EP disclosed
WO-2023064879-A1 COMPOUNDS AND METHODS FOR MODULATING NUCLEIC ACID SPLICING REMIX THERAPEUTICS INC. (US) 2023-04-20 — — WO disclosed
EP-4132936-A1 COMPOUNDS AND METHODS FOR MODULATING SPLICING Remix Therapeutics Inc. (US) 2023-02-15 — — EP disclosed
Send feedback